SAENGER BRADLEY bought TNXP
February 24, 2026 · Form 4 insider transaction
SAENGER BRADLEY bought 39,012 shares of Tonix Pharmaceuticals Holding Corp. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
39,012
Price
$0.00
Total value
N/A
InsiderSAENGER BRADLEY
Role—
SecurityStock Option
Transaction codeA: Grant or award
Transaction dateFebruary 24, 2026
Filing dateFebruary 26, 2026
Shares owned after39,012
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended.; One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months.